Clover Health Investments, Corp. CLOV
We take great care to ensure that the data presented and summarized in this overview for CLOVER HEALTH INVESTMENTS, CORP. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CLOV
View all-
Vanguard Group Inc Valley Forge, PA23.1MShares$57 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA9.72MShares$24 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.54MShares$23.6 Million0.0% of portfolio
-
State Street Corp Boston, MA8.95MShares$22.1 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny7.71MShares$19.1 Million0.03% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA4.46MShares$11 Million0.01% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA4.27MShares$10.6 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL3.37MShares$8.33 Million0.0% of portfolio
-
Divisadero Street Capital Management, LP Miami, FL2.77MShares$6.84 Million0.51% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA2.7MShares$6.67 Million0.0% of portfolio
Latest Institutional Activity in CLOV
Top Purchases
Top Sells
About CLOV
Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
Insider Transactions at CLOV
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 14
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
7,459
-0.6%
|
$14,918
$2.47 P/Share
|
|
Nov 08
2025
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
85,535
-0.86%
|
$171,070
$2.67 P/Share
|
|
Nov 04
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Open market or private sale
|
Direct |
30,385
-1.08%
|
$91,155
$3.58 P/Share
|
|
Oct 31
2025
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
111,691
-2.41%
|
$335,073
$3.53 P/Share
|
|
Oct 31
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
169,607
-6.17%
|
$508,821
$3.53 P/Share
|
|
Oct 31
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
131,430
-2.24%
|
$394,290
$3.53 P/Share
|
|
Oct 31
2025
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
124,378
-4.97%
|
$373,134
$3.53 P/Share
|
|
Oct 29
2025
|
Peter J. Kuipers Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
217,382
-3.54%
|
$652,146
$3.64 P/Share
|
|
Oct 18
2025
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
48,305
-2.02%
|
$96,610
$2.71 P/Share
|
|
Oct 17
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Open market or private sale
|
Direct |
16,514
-0.56%
|
$33,028
$2.69 P/Share
|
|
Oct 15
2025
|
Brady Patrick Priest CEO of Home Care |
SELL
Payment of exercise price or tax liability
|
Direct |
82,778
-3.35%
|
$165,556
$2.8 P/Share
|
|
Oct 15
2025
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
242,580
-2.39%
|
$485,160
$2.8 P/Share
|
|
Oct 15
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
57,249
-3.91%
|
$114,498
$2.8 P/Share
|
|
Oct 15
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
71,432
-2.35%
|
$142,864
$2.8 P/Share
|
|
Oct 15
2025
|
Conrad Wai CEO, Counterpart Health |
SELL
Payment of exercise price or tax liability
|
Direct |
92,181
-6.75%
|
$184,362
$2.8 P/Share
|
|
Oct 07
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Open market or private sale
|
Direct |
2,012
-0.07%
|
$4,024
$2.65 P/Share
|
|
Oct 03
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Payment of exercise price or tax liability
|
Direct |
8,706
-0.29%
|
$17,412
$2.59 P/Share
|
|
Oct 01
2025
|
Andrew Toy Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
308,950
-2.95%
|
$617,900
$2.62 P/Share
|
|
Sep 17
2025
|
Jamie L. Reynoso CEO, Medicare Advantage |
SELL
Open market or private sale
|
Direct |
4,914
-0.16%
|
$14,742
$3.09 P/Share
|
|
Sep 15
2025
|
Karen Soares General Counsel & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,403
-0.44%
|
$19,209
$3.14 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 971K shares |
|---|---|
| Exercise of conversion of derivative security | 1.67M shares |
| Open market or private purchase | 473K shares |
| Payment of exercise price or tax liability | 6.61M shares |
|---|---|
| Open market or private sale | 640K shares |